Announced Tue, 28 Jul · 18:21 IST
Q1 FY27 earnings call filed; revenue up 59% YoY, guides 25% full-year growth
Order Pipeline DisclosedMgmt Evaded Key QuestionInvestor Communications View source PDFExplain this filing
ACUTAAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-4.4%1-day move
₹3381.10
prior close
₹3329.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.9-1.0-1.5-4.4-8.7-7.7-4.5-2.7-2.7-4.6———
Up moveDown movePending
AI summary
Acutaas Chemicals Q1 FY27 revenue at INR329.7 cr, up 59.1% YoY. EBITDA more than doubled YoY to INR113.1 cr, margin at 34.3% (up 973 bps). PAT up 70% at INR74.9 cr. Pharma intermediates grew 76.5%. Management guided 25% revenue growth and stable margins for FY27, confident of beating the INR1,000 cr CDMO revenue target. Battery chemicals plant commissioned with ramp-up to full capacity by FY29. Net cash at INR314 cr.
Likely market impact
Strong beat with 59% revenue growth and sharp margin expansion. Battery chemicals and semiconductor plants offer strong future growth drivers.